{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:04:22Z","timestamp":1777514662449,"version":"3.51.4"},"reference-count":63,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J R Army Med Corps"],"accepted":{"date-parts":[[2016,10,27]]},"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>Meningococcal disease is a worldwide life-threatening infection associated in many cases with debilitating long-term sequelae, both within the military and civilian populations. Military recruits are at a higher risk of acquiring this infection due to numerous factors, such as young recruits in the age group 18\u201325\u2005years, high carriage rates of meningococci, communal and crowed living quarters and global deployment or training in regions with different meningococcal serogroup epidemiology. Although these increased risk factors among young recruits remain, the increased incidence of disease is now historic. Numerous outbreaks have been reported among military personnel, however although the incidence of the disease continues to decrease, there are still sporadic cases. The non-specific symptoms, sudden onset and rapid progression of the infection results in a limited time frame to both diagnose and successfully treat the patient. Many developments have been made in relation to the microbiological diagnosis of the disease, particularly in the era of molecular diagnostics, which have the potential to diagnose the infection more quickly. Developments in vaccinology, and in particular with relation to biotechnology and reverse vaccinology, have led to the availability of new meningococcal vaccines, further enabling disease prevention. This paper outlines the history of meningococcal disease in relation to the military and highlights the new developments in both diagnostics and vaccination, which have the potential to diagnose, treat and control meningococcal disease in a more efficient manner.<\/jats:p>","DOI":"10.1136\/jramc-2016-000695","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T21:20:26Z","timestamp":1483132826000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Meningococcal disease: has the battle been won?"],"prefix":"10.1136","volume":"163","author":[{"given":"Beverley C","family":"Millar","sequence":"first","affiliation":[{"name":"Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J A","family":"Moore","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Moore","sequence":"additional","affiliation":[{"name":"Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK"},{"name":"School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"2025081312150617000_163.4.235.1","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-89-01-01"},{"key":"2025081312150617000_163.4.235.2","unstructured":"Phair JJ . (1958) Meningococcal meningitis. In: Coates JB , Hoff C , Hoff PM, eds . Preventive medicine in WWII, volume IV, communicable diseases, transmitted chiefly through respiratory and alimentary tracts. Washington DC. http:\/\/history.amedd.army.mil\/booksdocs\/wwii\/PM4\/CH11.Meningitis.htm (accessed 25 Jul 2016)."},{"key":"2025081312150617000_163.4.235.3","doi-asserted-by":"publisher","DOI":"10.1179\/2047773213Y.0000000119"},{"key":"2025081312150617000_163.4.235.4","doi-asserted-by":"publisher","DOI":"10.1086\/344273"},{"key":"2025081312150617000_163.4.235.5","first-page":"400","article-title":"Biological warfare and bioterrorism: a historical review","volume":"17","author":"Riedel","year":"2004","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2025081312150617000_163.4.235.6","doi-asserted-by":"publisher","DOI":"10.3201\/eid1809.120257"},{"key":"2025081312150617000_163.4.235.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1943.02840400012004"},{"key":"2025081312150617000_163.4.235.8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2105\/AJPH.33.12.1461","article-title":"Laboratory methods used in determining the value of sulfadiazine as a mass prophylactic against meningococcic infections","volume":"33","author":"Kuhns","year":"1943","journal-title":"Am J Public Health Nations Health"},{"key":"2025081312150617000_163.4.235.9","first-page":"6","article-title":"Global review of meningococcal disease. A shifting etiology","volume":"1","author":"Leimkugel","year":"2009","journal-title":"J Bacteriol Res"},{"key":"2025081312150617000_163.4.235.10","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-30-01-01"},{"key":"2025081312150617000_163.4.235.11","doi-asserted-by":"publisher","DOI":"10.3201\/eid1904.111799"},{"key":"2025081312150617000_163.4.235.12","unstructured":"CDC. Laboratory Methods for the Diagnosis of Meningitis. CHAPTER 7 Identification and Characterization of Neisseria meningitidis. http:\/\/www.cdc.gov\/meningitis\/lab-manual\/chpt07-id-characterization-nm.html (accessed 25 Jul 2016)."},{"key":"2025081312150617000_163.4.235.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00057.x"},{"key":"2025081312150617000_163.4.235.14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01447-15"},{"key":"2025081312150617000_163.4.235.15","unstructured":"PHL England 2015. The green book. Meningococcal, Chapter 22. 2015. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/462629\/2904512_Green_Book_Chapter_22_v6_0W.PDF (accessed 25 Jul 2016)."},{"key":"2025081312150617000_163.4.235.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.07.007"},{"key":"2025081312150617000_163.4.235.17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/QAI.0000000000000822","article-title":"Cost-effectiveness of meningococcal vaccination among men who have sex with men in New York city","volume":"71","author":"Simon","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025081312150617000_163.4.235.18","doi-asserted-by":"crossref","first-page":"pii:21016","DOI":"10.2807\/1560-7917.ES2015.20.3.21016","article-title":"Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014","volume":"20","author":"Aubert","year":"2015","journal-title":"Euro Surveill"},{"key":"2025081312150617000_163.4.235.19","doi-asserted-by":"crossref","first-page":"pii:20523","DOI":"10.2807\/1560-7917.ES2013.18.28.20523","article-title":"A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013","volume":"18","author":"Marcus","year":"2013","journal-title":"Euro Surveill"},{"key":"2025081312150617000_163.4.235.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.3019.509"},{"key":"2025081312150617000_163.4.235.21","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800050196"},{"key":"2025081312150617000_163.4.235.22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/003655400458820","article-title":"Surveillance of cases of meningococcal disease associated with military recruits studied for meningococcal carriage","volume":"32","author":"Andersen","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"2025081312150617000_163.4.235.23","unstructured":"BMJ Best Practice Meningococcal Disease. http:\/\/bestpractice.bmj.com\/best-practice\/monograph\/542.html (accessed 25 Jul 2016)."},{"key":"2025081312150617000_163.4.235.24","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.34.1.40"},{"key":"2025081312150617000_163.4.235.25","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(68)90156-3"},{"key":"2025081312150617000_163.4.235.26","first-page":"275","article-title":"Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964\u201370","volume":"45","author":"Artenstein","year":"1971","journal-title":"Bull World Health Organ"},{"key":"2025081312150617000_163.4.235.27","first-page":"18","article-title":"Surveillance snapshot: cases of service member meningococcal disease reported to the Naval Health Research Center Laboratory-based Meningococcal Disease Surveillance Program, 2006\u20132014","volume":"21","author":"Broderick","year":"2014","journal-title":"MSMR"},{"key":"2025081312150617000_163.4.235.28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3201\/eid2102.141037","article-title":"Meningococcal disease in US military personnel before and after adoption of conjugate vaccine","volume":"21","author":"Broderick","year":"2015","journal-title":"Emerging Infect Dis"},{"key":"2025081312150617000_163.4.235.29","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1017\/S0950268816001308","article-title":"Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease","volume":"144","author":"V\u00e1zquez","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2025081312150617000_163.4.235.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.01.007"},{"key":"2025081312150617000_163.4.235.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.2922.900"},{"key":"2025081312150617000_163.4.235.32","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.vaccine.2015.05.027","article-title":"Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers","volume":"33","author":"Findlow","year":"2015","journal-title":"Vaccine"},{"key":"2025081312150617000_163.4.235.33","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-2016-000634"},{"key":"2025081312150617000_163.4.235.34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.2003.01839.x"},{"key":"2025081312150617000_163.4.235.35","doi-asserted-by":"crossref","first-page":"e0122922","DOI":"10.1371\/journal.pone.0122922","article-title":"Clinical evaluation of a loop-mediated isothermal amplification (LAMP) assay for rapid detection of Neisseria meningitidis in cerebrospinal fluid","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS ONE"},{"key":"2025081312150617000_163.4.235.36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1473-3099(15)70038-1","article-title":"Diagnostic accuracy of loop-mediated isothermal amplification as a near-patient test for meningococcal disease in children: an observational cohort study","volume":"15","author":"Bourke","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2025081312150617000_163.4.235.37","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"2025081312150617000_163.4.235.38","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"2025081312150617000_163.4.235.39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3947\/ic.2013.45.1.113","article-title":"Commencement of the meningococcal vaccination for the Republic of Korea army","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother"},{"key":"2025081312150617000_163.4.235.40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/124.1.39"},{"key":"2025081312150617000_163.4.235.41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.31.6.962","article-title":"Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland","volume":"31","author":"Renkonen","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"2025081312150617000_163.4.235.42","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.1310"},{"key":"2025081312150617000_163.4.235.43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1349"},{"key":"2025081312150617000_163.4.235.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197002192820803"},{"key":"2025081312150617000_163.4.235.45","first-page":"279","article-title":"Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969\u201370","volume":"45","author":"Gold","year":"1971","journal-title":"Bull World Health Organ"},{"key":"2025081312150617000_163.4.235.46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1385"},{"key":"2025081312150617000_163.4.235.47","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.vaccine.2014.05.001","article-title":"Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel","volume":"32","author":"Patel","year":"2014","journal-title":"Vaccine"},{"key":"2025081312150617000_163.4.235.48","doi-asserted-by":"crossref","first-page":"pii:21188","DOI":"10.2807\/1560-7917.ES2015.20.28.21188","article-title":"Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015","volume":"20","author":"Campbell","year":"2015","journal-title":"Euro Surveill"},{"key":"2025081312150617000_163.4.235.49","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70341-4"},{"key":"2025081312150617000_163.4.235.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.09.035"},{"key":"2025081312150617000_163.4.235.51","doi-asserted-by":"crossref","first-page":"D32","DOI":"10.1016\/j.vaccine.2015.05.101","article-title":"Vaccines for prevention of group B meningococcal disease: not your father's vaccines","volume":"33","author":"Harrison","year":"2015","journal-title":"Vaccine"},{"key":"2025081312150617000_163.4.235.52","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3201\/eid2108.141361","article-title":"Response strategies against meningitis epidemics after elimination of serogroup A meningococci, Niger","volume":"21","author":"Ma\u00efnassara","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2025081312150617000_163.4.235.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.036"},{"key":"2025081312150617000_163.4.235.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(88)91907-X"},{"key":"2025081312150617000_163.4.235.55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-4015"},{"key":"2025081312150617000_163.4.235.56","first-page":"608","article-title":"Serogroup B meningococcal disease outbreak and carriage evaluation at a college\u2014Rhode Island, 2015","volume":"64","author":"Soeters","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025081312150617000_163.4.235.57","unstructured":"de Wals P . Results of a mass immunisation campaign with 4-components serogroup b meningococcal vaccine (4CMenB) in Quebec, Canada. In: Proceedings of Meningitis & Septicaemia in Children & Adults 2015. London, UK: Royal Society of Medicine. MRF Conference December 2015. http:\/\/www.meningitis.org\/conference2015#sthash.Ywj176IM.dpuf (accessed 25 Jul 2016)."},{"key":"2025081312150617000_163.4.235.58","first-page":"225","article-title":"The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state","volume":"13","author":"Stroffolini","year":"1990","journal-title":"Microbiologica"},{"key":"2025081312150617000_163.4.235.59","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90236-Q"},{"key":"2025081312150617000_163.4.235.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2009.04.290"},{"key":"2025081312150617000_163.4.235.61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3923\/jms.2009.51.54","article-title":"Meningococcal meningitis control in Iran: five year comparative study 2000\u20132004","volume":"9","author":"Mehrabi Tavana","year":"2009","journal-title":"J Med Sci"},{"key":"2025081312150617000_163.4.235.62","first-page":"298","article-title":"Effectiveness of the meningococcal vaccination programme for British Armed Forces recruits","volume":"3","author":"Bergman","year":"2000","journal-title":"Commun Dis Public Health"},{"key":"2025081312150617000_163.4.235.63","unstructured":"British Army. 2014. Drumhead Service held in memory of VC hero. 17 November 2014. http:\/\/www.army.mod.uk\/news\/26713.aspx (accessed 25 Jul 2016)."}],"container-title":["Journal of the Royal Army Medical Corps"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jramc-2016-000695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T19:15:21Z","timestamp":1755112521000},"score":1,"resource":{"primary":{"URL":"https:\/\/militaryhealth.bmj.com\/lookup\/doi\/10.1136\/jramc-2016-000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,2]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/jramc-2016-000695"],"URL":"https:\/\/doi.org\/10.1136\/jramc-2016-000695","relation":{},"ISSN":["0035-8665","2052-0468"],"issn-type":[{"value":"0035-8665","type":"print"},{"value":"2052-0468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}